Pioglitazone metformin tablets have hypoglycemic effect. Pioglitazone Metformin Tablet is a compound preparation, the main ingredients of which are pioglitazone and metformin, and is used for type 2 diabetes mellitus that does not respond well to metformin hydrochloride or pioglitazone hydrochloride alone. Adverse reactions: nausea, vomiting, diarrhea, dizziness, edema, hypoglycemia, and rash may occur after use of the drug. Contraindications: contraindicated in persons with significant abnormal cardiac functional status; contraindicated in persons with abnormal renal function; contraindicated in persons with metabolic acidosis; contraindicated in persons who are allergic to the product. Pioglitazone metformin tablets should be used in accordance with medical advice, do not use on their own.